PDFSegment Information [45.0KB]

(billion yen)

FYE 3/'20FYE 3/'21FYE 3/'22
Cardiac and Vascular Company350.6328.5373.5
General Hospital Company171.0175.5181.5
Blood and Cell Technologies Company107.2109.5115.0

※Terumo Corporation has adopted IFRS from the fiscal year ended March 31, 2018.

※FY2021 Guidance is disclosed in a range format due to the impact of COVID-19 pandemic.
Bar graph shows the lowest in the range.

Revenue by Business Segment

Cardiac and Vascular Company

General Hospital Company

Blood and Cell Technologies Company